PODLOGAR SUSAN M has filed 17 insider transactions across 3 companies since February 2023.
Most recent transaction: a option exercise of 2355 shares of LivaNova PLC ($LIVN) on December 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | LivaNova PLC | $LIVN | PODLOGAR SUSAN M | Director | M | Restricted Stock Units | 2355 | $0.00 | 0.0000 | 55,153,000 | 100.00% | 0.00% |
| Dec. 15, 2025 | LivaNova PLC | $LIVN | PODLOGAR SUSAN M | Director | F | Ordinary Shares | 269 | $63.06 | 2,086.0000 | 55,153,000 | 11.42% | 0.00% |
| Dec. 15, 2025 | LivaNova PLC | $LIVN | PODLOGAR SUSAN M | Director | M | Ordinary Shares | 2355 | $0.00 | 2,355.0000 | 55,153,000 | 9999.99% | 0.00% |
| June 15, 2025 | LivaNova PLC | $LIVN | PODLOGAR SUSAN M | Director | A | Restricted Stock Units | 4042 | $0.00 | 4,042.0000 | 54,574,000 | 9999.99% | 0.01% |
| Dec. 23, 2024 | Tevogen Bio Holdings Inc. | $TVGN | PODLOGAR SUSAN M | Director | A | Common Stock | 240000 | $0.00 | 433,923.0000 | 0 | 123.76% | 0.00% |
| Dec. 15, 2024 | LivaNova PLC | $LIVN | PODLOGAR SUSAN M | Director | A | Restricted Stock Units | 2355 | $0.00 | 2,355.0000 | 54,585,000 | 9999.99% | 0.00% |
| March 1, 2024 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | F | Common Stock | 1907 | $69.73 | 79,794.0000 | 762,300,000 | 2.33% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | A | Common Stock | 4013 | $0.00 | 68,555.0000 | 762,300,000 | 6.22% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | A | Employee Stock Options (right to buy) | 12040 | $0.00 | 12,040.0000 | 762,300,000 | 9999.99% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | A | Common Stock | 26968 | $0.00 | 95,523.0000 | 762,300,000 | 39.34% | 0.00% |
| Feb. 27, 2024 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | F | Common Stock | 13822 | $69.16 | 81,701.0000 | 762,300,000 | 14.47% | 0.00% |
| Feb. 14, 2024 | Tevogen Bio Holdings Inc. | $TVGN | PODLOGAR SUSAN M | Director | A | Common Stock | 193923 | $0.00 | 193,923.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | F | Common Stock | 1981 | $71.27 | 64,542.0000 | 808,900,000 | 2.98% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | A | Employee Stock Options (right to buy) | 10979 | $0.00 | 10,979.0000 | 808,900,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | F | Common Stock | 13223 | $71.73 | 66,523.0000 | 808,900,000 | 16.58% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | A | Common Stock | 29893 | $0.00 | 79,746.0000 | 808,900,000 | 59.96% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | PODLOGAR SUSAN M | EVP & Chief HR Officer | A | Common Stock | 3660 | $0.00 | 49,853.0000 | 808,900,000 | 7.92% | 0.00% |